John R. Oishei Children's Hospital, sometimes known as simply Oishei Children's is a women's and children's hospital in Buffalo, New York, that opened on November 10, 2017, and provides pediatric ...

During the past decade, Women and Children's Hospital of Buffalo conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 26 clinical trials were completed, i.e. on average, 108.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 11 clinical trials were completed. i.e. 157.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Women and Children's Hospital of Buffalo" #1 sponsor was "State University of New York at Buffalo" with 12 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials sponsored, "University of Rochester" with 3 trials sponsored, "CF Therapeutics Development Network Coordinating Center" with 2 trials sponsored and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Women and Children's Hospital of Buffalo" #1 collaborator was "Cystic Fibrosis Foundation" with 11 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "Glaxo Wellcome" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Children's Hospital Medical Center, Cincinnati" with 2 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 79 trials.

According to Clinical.Site data, the most researched conditions in "Women and Children's Hospital of Buffalo" are "Cystic Fibrosis" (13 trials), "HIV Infections" (4 trials), "Asthma" (3 trials), "Bronchopulmonary Dysplasia" (3 trials) and "Diabetes Mellitus, Type 1" (2 trials). Many other conditions were trialed in "Women and Children's Hospital of Buffalo" in a lesser frequency.

Most popular intervention types in "Women and Children's Hospital of Buffalo" are "Drug" (45 trials), "Other" (8 trials), "Biological" (7 trials), "Device" (5 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "0.9% Isotonic Saline (IS)" (2 trials), "7% Hypertonic Saline (HS)" (2 trials), "Ivacaftor" (2 trials) and "Pletal" (2 trials). Other intervention names were less common.

The vast majority of trials in "Women and Children's Hospital of Buffalo" are 74 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Women and Children's Hospital of Buffalo". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Women and Children's Hospital of Buffalo, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Women and Children's Hospital of Buffalo, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 16 trials that are defined as “Not Applicable".

Women and Children's Hospital of Buffalo has several departments that took part in Clinical trials: "CF Therapeutics Development Center of Western New York" - 5 trials